Efficacy Of Platinum Re-Challenge In Metastatic Urothelial Carcinoma (Muc): A Retrospective Comparison Of Chemotherapy Regimens.

Risa Liang Wong,Lorin Ferris,Olivia A Do,Sarah K Holt,Jorge Ramos,Simon J. Crabb,Cora N. Sternberg,Joaquim Bellmunt,Sylvain Ladoire,Ugo De Giorgi,Lauren C Harshman,Ulka N. Vaishampayan,Andrea Necchi,Sandy Srinivas,Sumanta K. Pal,Guenter Niegisch,Tanya B. Dorff,Matt D. Galsky,Evan Y. Yu

JOURNAL OF CLINICAL ONCOLOGY（2021）

引用 0|浏览8

暂无评分

摘要

459Background: First-line platinum-based combination chemotherapy (fPBC) is standard of care for fit patients with mUC. Further lines of therapy include immuno-oncology agents, erdafitinib, and enf...

查看译文

关键词

Combination chemotherapy,Metastatic Urothelial Carcinoma,Chemotherapy,Oncology,Medicine,Internal medicine,Re challenge,Standard of care

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要